Clinical Safety of Long-Acting β 2 -Agonist and Inhaled Corticosteroid Combination Therapy in COPD

By Decramer Marc   Ferguson Gary  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 3, Iss. 3, 2006-09 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy of Long-Acting  2 -Adrenoceptor Agonists and Corticosteroids for Asthma

By Chung K. Fan  

Treatments in Respiratory Medicine, Vol. 3, Iss. 5, 2004-01 ,pp. : 279-289

Adis International

Access to resources Recommend Favorite

Tolerability Profiles of Leukotriene Receptor Antagonists and Long-Acting β2-Adrenoceptor Agonists in Combination with Inhaled Corticosteroids for Treatment of Asthma: A Review

By Colucci R.   Fornai M.   Tuccori M.   Antonioli L.   Pasqualetti G.   Blandizzi C.   Tacca M. Del  

Journal of Asthma, Vol. 44, Iss. 6, 2007-07 ,pp. : 411-422

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β₂-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler

By Berger William E.   Noonan Michael J.  

Journal of Asthma, Vol. 47, Iss. 4, 2010-05 ,pp. : 447-459

Informa Healthcare

Access to resources Recommend Favorite

Combination Inhalers Containing Inhaled Corticosteroids and Long-Acting β 2 -Agonists: Improved Clinical Efficacy and Dosing Options in Patients with Asthma

By Ankerst Jaro  

Journal of Asthma, Vol. 42, Iss. 9, 2005-10 ,pp. : 715-724

Informa Healthcare

Access to resources Recommend Favorite